IRCT2017050833875N1已完成3 期
Effect of intravitreal injection of Bevacizumab and subtenon injection of Triamcinolone and topical diclofenac eye drop in preventing the incidence of diabetic macular edema after phaco with intraocular lens implementing
Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years(—)
- 性别
- All
入选标准
- •Inclusion Criteria: Diabetic patients with cataract and without diabetic macular edema; Nonproliferation diabetic retinopathy.
排除标准
- •Glaucoma; Eye trauma; Laser therapy 12 months prior to cataract surgery; Any history of eye surgery 6 months ago.
研究者
相似试验
已完成
2 期
Intravitreal Bevacizumab in acute Branch Retinal Vein Occlusion(BRVO)Branch Retinal Vein occlusion.Other retinal vascular occlusionsIRCT201106214856N2Vice chancellor for research, Baqiyatallah University of Medical Science20
进行中(未招募)
不适用
Silmän sisäisten lääkeainepistosten aikaan saama hermoston uudelleen muokaantuvuusEUCTR2012-000765-20-FIKuopion yliopistollinen sairaala/silmätautien poliklinikka
招募中
4 期
Efficacy of bevacizumab by intravitreal route in choroidal neovascular membrane of eye.CTRI/2016/09/007288Govt medical college and sir takhtsinhji hospital bhavnagr30
已完成
不适用
Evaluate the effect of intravitreal Bevacizumab injection for ocular proliferative diseaseschoroidal neovascularization,proliferative diabetic retinopathy, central retinal vein occlusion neovascular glaucomaJPRN-UMIN000020467agasaki University Hospital90
已完成
不适用
The effect of intra-vitreal injection of bevacizumab for vascular endothelial factor-related intraocular diseases.choroidal neovascularization, retinal vein occlusion, diabetic retinopathy, diabetic maculopathy, neovascular glaucomaJPRN-UMIN000013974Department of Ophthalmology, Matsumoto Dental University3
